גאלבוס 50 מ"ג

البلد: إسرائيل

اللغة: العبرية

المصدر: Ministry of Health

العنصر النشط:

VILDAGLIPTIN 50 MG

متاح من:

NOVARTIS PHARMA SERVICES AG

ATC رمز:

A10BH02

الشكل الصيدلاني:

TABLETS

طريقة التعاطي:

PER OS

المصنعة من قبل:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

المجموعة العلاجية:

VILDAGLIPTIN

الخصائص العلاجية:

Galvus is indicated as an adjunct to diet and exercise in patients with type 2 diabetes mellitus• As monotherapy, if diet and exercise are not sufficient, or• In combination with metformin, or a sulfonylurea if treatment with these oral antidiabetics does not offer sufficient control of blood glucose.As triple oral therapy in combination with• a sulphonylurea and metformin when diet and exercise plus dual therapy with these agents do not provide adequate glycaemic control. Galvus is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycaemic control.

تاريخ الترخيص:

2013-11-01